Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Leber Hereditary Optic Neuropathy
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Recruiting
Phase:
Phase 2/Phase 3
Intervention Type:
Drug
Participants:
14
Start Date:
March 26, 2019
Study of Efficacy of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 3
Intervention Type:
Drug, Genetic
Participants:
90
Start Date:
March 12, 2018
Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Search for trials
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 3
Intervention Type:
Genetic, Other
Participants:
61
Start Date:
January 9, 2018
Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials
Clinical Trial
Status:
Active, not recruiting
Phase:
N/A
Intervention Type:
Drug
Participants:
120
Start Date:
January 8, 2018
Efficacy Study of Gene Therapy for The Treatment of Acute LHON Onset Within Three Months
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 2/Phase 3
Intervention Type:
Drug
Participants:
159
Start Date:
December 27, 2017
A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy
Clinical Trial
Status:
Active, not recruiting
Intervention Type:
Drug
Participants:
250
Start Date:
September 2016
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy (LHON)
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 4
Intervention Type:
Drug
Participants:
250
Start Date:
May 2016
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Clinical Trial
Status:
Recruiting
Phase:
N/A
Intervention Type:
Procedure
Participants:
500
Start Date:
January 2016
Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 1
Intervention Type:
Drug
Participants:
30
Start Date:
July 14, 2014
An Open-label Dose Escalation Study of an Adeno-associated Virus Vector (scAAV2-P1ND4v2) for Gene Therapy of Leber's Hereditary Optic Neuropathy (LHON) Caused by the G11778A Mutation in Mitochondrial DNA
Showing 1-9 of 9